Home › Peripheral Arterial Disease › Tennessee › Knoxville
Peripheral Arterial Disease clinical trials in Knoxville, TN
4 studies for Peripheral Arterial Disease are looking for participants at sites in and around Knoxville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
RecruitingPhase 3
- Tennova TCMC, Knoxville
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
RecruitingPhase 3
- East Coast Institute for Research - Jefferson City, Jefferson City · 26 mi away
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Dialysis Clinic Inc - University Nephology, Knoxville
- Knoxville Kidney Center PLLC, Knoxville
REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center
Recruiting
- University of Tennessee Medical Center, Knoxville
About Peripheral Arterial Disease
Peripheral arterial disease (PAD) happens when there is a narrowing of the blood vessels outside of your heart. Learn about symptoms and treatment.
More about Peripheral Arterial Disease on MedlinePlus
Peripheral Arterial Disease trials in other cities
- Boston, MA10 studies
- Dallas, TX9 studies
- Cleveland, OH9 studies
- Chicago, IL9 studies
- Houston, TX8 studies
- Omaha, NE7 studies
- Gainesville, FL7 studies
- Miami, FL6 studies
- Minneapolis, MN6 studies
- Nashville, TN6 studies
- Detroit, MI6 studies
- Aurora, CO6 studies
Other studies in Knoxville
- Non-Small Cell Lung Cancer14 studies
- Obesity10 studies
- Lung Cancer10 studies
- Breast Cancer9 studies
- Cancer (all types)8 studies
- Overweight7 studies
- Heart Failure7 studies
- Metastatic Cancer7 studies
- Cardiovascular Disease6 studies
- Melanoma5 studies
- Type 2 Diabetes5 studies
- High Blood Pressure5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.